Back to results
US 10,208,068 B2Granted
Macrocycles as factor XIa inhibitors
AssigneeBristol-Myers Squibb Company
InventorsDonald J. P. Pinto, James R. Corte, Wu Yang, William R. Ewing
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of Formula (Ia): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
Claims3
A compound selected from
- or a pharmaceutically acceptable salt thereof.
A compound of Formula (Ia):
- or a pharmaceutically acceptable salt thereof, wherein:
- ring A is selected from aryl and a 5- to 6-membered heterocycle comprising:
- carbon atoms and 1-4 heteroatoms selected from N, NH, N(C1-4 alkyl), S(O)p, and O, wherein said aryl and heterocycle are optionally substituted with R1;
- ring B is a pyridazine optionally substituted with R10;
- ring C is a 4- to 6-membered heterocycle comprising:
- carbon atoms and 1-4 heteroatoms selected from N, NR9, S(O)p, and O, wherein said heterocycle is optionally substituted with R2;
- X is selected from C4-8 alkylene and C4-8 alkenylene, wherein said alkylene and alkenylene are substituted with R4 and R5;
- alternatively one or more of the carbon atoms of said alkylene and alkenylene may be replaced by O, C═O, S(O)p, NH, and N(C1-4 alkyl);
- Y is —CR6R7—NH—;
- R1 is selected from H, halogen, NO2, C1-6 alkyl, OH, haloalkyl, alkoxy, haloalkoxy, —C(═O)C1-3 alkyl, and CN;
- R2 is selected from H, ═O, OH, NH2, CF3, halogen, C1-4 alkyl (optionally substituted with OH), C1-3 alkoxy, and C(O)C1-3 alkyl;
- R3 is selected from H and C1-4 alkyl;
- alternatively, R2 and R3, together with the atoms to which they are directly or indirectly attached, form a ring;
- R4 and R5 are independently selected from H, halogen, C1-6 alkyl, OH, NH2, —CH2NH2, C1-4 haloalkyl, —OCH2F, —OCHF2, —OCF3, NH(C1-4 alkyl), N(C1-4 alkyl)2, C1-4 alkoxy, —CH2OH, and —CH2O(C1-4 alkyl);
- when R4 and R5 are not attached to the same carbon atom, they may be taken together with the carbon atoms to which they are attached to form a carbocycle;
- R6 is selected from H, halogen, C(O)OH, and C(O)O(C1-4 alkyl);
- R7 is selected from H, C1-4 alkyl, and CF3;
- alternatively, R6 and R7 together are ═O;
- R8 is, independently at each occurrence, selected from H, halogen, haloalkyl, CN, —(CH2)nOH, NR12R12, —CH2NH2, C(O)OH, —(CH2)n—NHC(O)OR12, —NHC(O)R12, —NHC(O)C(O)R12, —NHC(N—CN)NHR12, —NHC(NH)NHR12, —N═CHNR12R12, —NHC(O)NR12R12, —NHS(O)2C1-4 alkyl, —(CH2)n—CONR12R12, —(CH2)nC(O)O(C1-4 alkyl), —NHC(O)OCH2(C(CH2)2)O—(CH2)n—C3-10 carbocycle, —(CH2)n—C3-10 carbocycle, and —(CH2)n-4-10-membered heterocycle wherein said carbocycle and heterocycle are optionally substituted with R13;
- R9 is selected from H and C1-4 alkyl;
- R10 is selected from H, halogen, CN, ═O, OH, NH2, C3-6 cycloalkyl, C1-4 alkyl, C1-4 alkoxy, and C1-4 haloalkyl;
- R11 is selected from H, halogen, and methyl;
- R12 is selected from H, C1-4 alkyl (optionally substituted with halogen, hydroxy, alkoxy, carboxy, alkoxycarbonyl, and arylalkyloxy), —(CH2)n—C3-10 carbocycle and —(CH2)n-4-10-membered heterocycle, wherein said carbocycle and heterocycle are optionally substituted with R13;
- R13 is selected from OH, halogen, C1-6 alkyl, C3-6 cycloalkyl, —(CH2)n—C(═O)OH, —(CH2)n—C(═O)OC1-4 alkyl, —(CH2)n—OC1-4 alkyl, and =0;
- n is, independently at each occurrence, selected from 0, 1, 2, 3, and 4;
- p is, independently at each occurrence, selected from 0, 1, and 2.
23 more elements
Dependencies are inferred from the claim text.